Stockreport

Cellect Biotechnology Announces Positive Outcome From Safety Review Committee; Successfully Transplants 9th Clinical Trial Patient

Cellect Biotechnology Ltd. - American Depositary Shares  (APOP) 
US:NASDAQ Investor Relations: cellect.co
PDF TEL AVIV, Israel, Aug. 12, 2019 /PRNewswire/ -- Following the one month data of the 9th patient, the Data and Safety Monitoring Board (DSMB) reviewed the safety data fro [Read more]